Fibroblast activation in vascular inflammation
Clopidogrel 150 vs. 75 mg day−1 in patients undergoing percutaneous coronary intervention: a meta-analysis
Serum osteoprotegerin is a predictor for incident cardiovascular disease and mortality in a general population: the Tromsφ Study
Hemostatic cardiovascular risk factors, common carotid–intima medial thickness and peripheral arterial disease in South Asians and African Caribbeans: a substudy to the Ethnic-Echocardiographic Heart of England Screening (E-ECHOES) Study
Rates of venous thromboembolism in multiple myeloma patients undergoing immunomodulatory therapy with thalidomide or lenalidomide: a systematic review and meta-analysis
Single intravenous administration of TB-402 for the prophylaxis of venous thromboembolism after total knee replacement: a dose-escalating, randomized, controlled trial
Traffic exposure and incident venous thromboembolism in the Atherosclerosis Risk in Communities (ARIC) Study
The study of the effect of splicing mutations in von Willebrand factor using RNA isolated from patients' platelets and leukocytes
T-cell responses in two unrelated hemophilia A inhibitor subjects include an epitope at the factor VIII R593C missense site
A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study)
Predicting the warfarin maintenance dose in elderly inpatients at treatment initiation: accuracy of dosing algorithms incorporating or not VKORC1 / CYP2C9 genotypes
Bortezomib delays the onset of factor VIII inhibitors in experimental hemophilia A, but fails to eliminate established anti-factor VIII IgG-producing cells
Prothrombin complex concentrate and recombinant prothrombin alone or in combination with recombinant factor X and FVIIa in dilutional coagulopathy: a porcine model
Patient-derived monoclonal antibodies directed towards beta2 glycoprotein-1 display lupus anticoagulant activity
The septic milieu triggers expression of spliced tissue factor mRNA in human platelets
Platelet binding and activity of a factor VIIa variant with enhanced tissue factor independent activity
The chemotherapy metabolite acrolein upregulates thrombin generation and impairs the protein C anticoagulant pathway in animal-based and cell-based models
A ride with ferric chloride
Mechanisms underlying FeCl3-induced arterial thrombosis
Release of sphingosine-1-phosphate from human platelets is dependent on thromboxane formation
Efficient phagocytosis of periodontopathogens by neutrophils requires plasma factors, platelets and TLR2
Contribution of the P2Y12 receptor-mediated pathway to platelet hyperreactivity in hypercholesterolemia
Factor XIII supports platelet activation and enhances thrombus formation by matrix proteins under flow conditions
Osteoprotegerin, a new actor in vasculogenesis, stimulates endothelial colony-forming cells properties
The putative diabetic plasma marker, soluble CD36, is non-cleaved, non-soluble and entirely associated with microparticles
Nomenclature of genetic variants in hemostasis
Collagen surfaces to measure thrombus formation under flow: possibilities for standardization
Anti-β2glycoprotein I antibodies from leprosy patients do not show thrombogenic effects in an in vivo animal model
Protein C inhibitor inhibits factor VIIa when bound to tissue factor
Factor V Leiden pseudo-homozygotes have a more pronounced hypercoagulable state than factor V Leiden homozygotes
Outcomes of saddle pulmonary embolism: a nested case-control study
Association between atopic diseases and venous thromboembolism: a case–control study in patients aged 45 years or less
Increased tissue factor expression in diabetes mellitus type 2 monocytes caused by insulin resistance
Clopidogrel differentially affects platelet-mediated thrombosis and inflammatory response in patients with acute coronary syndromes
External quality assurance for the PFA-100®
Calibration of combined thromboplastins with the International Standard for Thromboplastin, rabbit, plain
High levels of glucose at time of diagnosing venous thrombosis: a case-control study
The association between platelet activation and FcγRIIa proteolysis
Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease: a rebuttal
Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease: reply to a rebuttal